7Peter J,Len A,Perumal S.Evaluation of the antiperoxidative effects of melatonin in ammonium acetate-treated Wistar rats[J].Pol J Pharmacol,2003,55:1031 - 1036.
5Staedt U, Leweling,Gladiseh R, et al. Effects of ornithine aspartate on plasma ammoniaand plasma aminoacids in patients with cirrbosis [J]. A doubleblind, randomized study using a four-fold crossover design [ J ]. J Bepatol 1993;19:424.
6Szerb JC, Butterworth RF. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system [J] .Prg Neurobiol, 1992 39:135.
7Renci P, Lockwood A, Mollen K, et al. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna,1998[R].Hepatology, 2002, 35:716-721.
8Shuliat'ev IS, I1'chenko Llu, Vinnitskaia EV, et al. Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis[J]. Eksp Klin Gastroenterol, 2002, (5) :38 - 41.
9Kireheis G, Wettstein M, Dahl S, et al. Clincal efficacy of L- ornithine -L-aspartate in the management of hepatic encephalopathy[J]. Metab Brain Dis, 2002,17:453-462.
10Di Campil C, Zileri Dal Verme L, Andrisani MC, et al. Advances in extracorporeal detoxifieation by MARS dialysis in patients with liver failure[J]. Curr Med Chem, 2003,10:341 - 348.
3Samir Ahboucha,Gilles Pomier-Layrargues,Roger F. Butterworth. Increased Brain Concentrations of Endogenous (Non-benzodiazepine) GABA-A Receptor Ligands in Human Hepatic Encephalopathy[J] 2004,Metabolic Brain Disease(3-4):241～251
4Samir Ahboucha,Roger F. Butterworth. Pathophysiology of Hepatic Encephalopathy: A New Look at GABA from the Molecular Standpoint[J] 2004,Metabolic Brain Disease(3-4):331～343
5A. R. Jayakumar,K. V. Rama Rao,P. Kalaiselvi,M. D. Norenberg. Combined Effects of Ammonia and Manganese on Astrocytes in Culture[J] 2004,Neurochemical Research(11):2051～2056
